CRISPR Therapeutics › Investing in modestly sized growth stocks can lead to significant returns, but oftentimes it requires ...
Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...
Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its type, transforming care options for sickle ...
A man with type 1 diabetes produces his own insulin after receiving genetically-modified donor islet cells, without the need ...
Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the time. Every now and then, though, the right opportunity comes along.
Scientists discover a rare gene, TMEM167A, causing infant diabetes and neurological issues, unlocking new insights and ...
The race to advance gene editing tech continues, spurred on by starry-eyed Silicon Valley investors, entrepreneurs and even ...
Advanced DNA sequencing technologies and a new model of stem cell research have enabled an international team to discover a ...
Advanced DNA sequencing technologies and a new stem cell research model have allowed an international team of scientists to ...
A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered cell transplants, without needing drugs to prevent rejection. The case, ...
Using advanced DNA sequencing technologies and new model of stem cell research the team from University of Exeter in the UK and Universite Libre de Bruxelles ...
Cathie Wood added to her stakes in Amazon, Coinbase, and CRISPR on Friday. All three stocks are trading between 29% and more than 50% below their recent highs. Amazon's weak guidance initially led to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results